(Total Views: 595)
Posted On: 10/06/2024 9:42:41 PM
Post# of 154137
Our Dr. Hansen & Cytomegalovirus:
" Dr. Hansen has 25 years of experience in the field of virology and immunology, 17 of which were focused on the development and utilization of the non-human primate (NHP) model for the study of host vs. pathogen interactions, disease state modeling, and vaccine development. He is currently an Associate Professor at OHSU, where he has earned recognition for his strong publication record. The majority of this published work focused on the development of a novel vaccine platform based on Cytomegalovirus. . "
____
It was Dr. Hansen who said working on 17 different types of Leronlimab.
Our PLS publication referenced HIV, Zika & Cytomegalovirus.
He rounds out the ecosystem of knowledge for giving LL-PLS the best possible odds of success.
( I forgot to re-read his bio until now )
" Dr. Hansen has 25 years of experience in the field of virology and immunology, 17 of which were focused on the development and utilization of the non-human primate (NHP) model for the study of host vs. pathogen interactions, disease state modeling, and vaccine development. He is currently an Associate Professor at OHSU, where he has earned recognition for his strong publication record. The majority of this published work focused on the development of a novel vaccine platform based on Cytomegalovirus. . "
____
It was Dr. Hansen who said working on 17 different types of Leronlimab.
Our PLS publication referenced HIV, Zika & Cytomegalovirus.
He rounds out the ecosystem of knowledge for giving LL-PLS the best possible odds of success.
( I forgot to re-read his bio until now )
(6)
(0)
